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The existence of a  functional idiotypic network was postulated by Jerne  (1) 
nearly one  decade  ago.  Many experiments  do  indeed prove  the  feasibility of 
idiotypic manipulations of the immune system (see reference  2  for a  review of 
this topic).  It still remains to be established however, that idiotype-antiidiotype 
interactions play a major role in the ontogenesis of the immune system and that 
such interactions control  its steady state.  Information on  these points  may be 
gained  from  the  characterization  of idiotypes  expressed  in  mice  during  the 
natural immunization event, as compared to those triggered by deliberate  im- 
munization with known antigens. 
Anti-levan response in BALB/c mice allows such an analysis. Bacterial levan 
is  considered  one  of the  most  common  natural  antigens  and  the  anti-levan 
immune response has been extensively analyzed by Lieberman et al. (3). Bacterial 
levan is a polyfructosan with/32- I and ~2-6 linkages. Bona et al. (4) have shown 
that the anti-/32-6  polyfructosan response  may be  elicited by immunization of 
young mice (from age  1 or 2 wk up) in contrast to the anti-/32-1  polyfructosan 
(anti-inulin)  response,  which  can  be  elicited  later  in  ontogeny.  The  idiotypes 
associated with anti-132-6 antibodies in BALB/c include two myeloma proteins, 
ABPC48  and  UPCI0  which  we  have  shown  in  a  previous  study (5)  to  share 
idiotypic  determinants.  The  obtaining  of a  battery  of monoclonal  syngeneic 
antiidiotypic  antibodies  permits  us  to  perform  very  sensitive  binding  assays 
specific for one  chosen  idiotope. 1 As shown here,  the analysis of the immune 
response  in adult  BALB/c mice injected with levan reveals  that ABPC48  idi- 
otopes  contribute  to  this  response.  Information on  the  idiotypic pattern  of a 
natural  immunization was also gained when ABPC48  idiotype expression and 
anti-levan titer were compared in young BALB/c mice immunized with bacterial 
levan and in nonimmunized mice. 
Material and Methods 
Mice.  BALB/c mice were purchased at the breeding Center of the Centre National 
de la  Recherche Scientifique (CNRS,  Orleans,  France) and grown in our own animal 
facilities. 
Antigens.  Bacterial levan of Bacillus subtilis origin (polyfructosan with/32-1 and ~2-6 
linkages) of several molecular weights (2 ×  107, 2 ×  10  ~ and 5 ×  104), plant levan (mol wt 
We shall refer to an idiotope as the structural element that participates in the binding of one 
given idiotype to one given monoclonal  antiidiotypic  antibody. Idiotopes are likely  to be overlapping 
regions on the variable domain of an immunoglobulin  rather than ponctual determinants (6). 
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7,500,/32-6 linkages), and inulin (mol wt 2,500,/32-1  linkages) were generous gifts from 
Dr. Rappoport (Institut Pasteur, Paris). The immunization procedure was 50 #g intraper- 
itoneally of bacterial levan (mol wt 2 x  107). Animals were bled through the retroorbital 
sinus. 
Monoclonal Immunoglobulins.  ABPC48 (IgA, r) and UPC 10 (IgG2a, x) myeloma proteins 
were kindly given to us by Pr Cazenave. Both immunoglobulins bind/32-6 polyfructosans. 
IDAs  2 are monoclonal antibodies produced by hybridomas derived from a BALB/c mouse 
immunized with ABPC48 (5). They are all IgGl, ~, with the exception of IDA23 (IgG2a, 
K). These monoclonal antibodies were purified on a Protein A Sepharose column (7). Fab 
fragment of IDA10 was prepared as described by Eisen et al. (8). 
ELISA Reagents and Buffers.  /3-Galactosidase was a generous gift from Dr. Nicole Guiso 
(lnstitut  Pasteur,  Paris).  Monoclonal antibodies and sheep anti-mouse immunoglobulins 
were coupled to the enzyme by ourselves according to Avrameas et al. (9). ELISA buffer 
was the same as described previously (5) except for the coating of microtiter plates (Nunc 
immunoplates I  Nunc,  Denmark): phosphate buffer 50  mM,  pH 8.  The p-nitrophenyl 
release was measured at 405 nm after  18 h  incubation at 37°C in a Titertek multiskan 
(Flow). 
Levan Binding Assay.  The capacity of sera or monoclonal antibodies to bind to bacterial 
levan was studied as follows: microtiter plates were coated with bacterial levan (tool wt 2 
x  105, 10 ug/ml) for 18 h at 4°C. Plates were washed and then incubated for 4 h at 4°C 
with  various dilutions  of sera or monoclonal antibodies,  washed three  times and  then 
incubated for 3 h with/3-galactosidase labeled-sheep anti-mouse Ig antibodies (20 ng per 
assay). After three washings, the plates were incubated for 18 h at 37°C with p-nitrophen- 
ylgalactopyranoside. 
Idiotype Binding Assay.  Microtiter plates were coated with purified monoclonal antiidi- 
otypic antibodies  (1  or  2  t~g/ml)  overnight  at  4°C.  Plates  were  washed  and  sera  or 
monoclonal antibodies were then incubated (4 h, 4°C); after three washings, plates were 
incubated for 3 h  with/3-galactosidase labeled monoclonal antiidiotypic antibodies (5 ng 
per assay).  Finally, plates were incubated for 18 h at 37°C with p-nitrophenylgalactopy- 
ranoside. By such sandwich assays, we are able to detect the presence of one (homologous 
sandwich)  or  two  (heterologous  sandwich  with  two  different  antiidiotypic  antibodies) 
idiotopes. Results are presented in micrograms equivalent of ABPC48 protein per milli- 
liter. This calculation was made from a standard binding curve obtained with ABPC48 
and clone in each experiment to control fluctuations from one experiment to another. 
Inhibition  of Binding Assays.  Inhibition of levan and idiotype binding assays was per- 
formed with a preincubation of sera or monoclonal antibodies with the inhibitor (levan, 
monoclonal antiidiotypic antibodies...) either 1 h at room temperature or overnight at 
4°C before incubation in ELISA plates. 
Results 
Quantitative Idiotype Binding Assays with Monoclonal Antibodies.  The presence of 
a  given idiotope  may be  detected  and  quantified  by a  sandwich  binding  assay 
involving a  monoclonal  antiidiotypic  antibody adsorbed  on  a  plastic  plate  and 
the  same antiidiotypic  antibody  conjugated  to  an  enzyme.  Fig.  1 a  shows  the 
binding  of  ABPC48  myeloma  protein  to  different  monoclonal  antiidiotypic 
antibodies in such a sandwich assay. In a given range of concentration of idiotype, 
this assay is quantitative  (for example, up to 500 ng/ml  for IDA23 or  1 ~g/ml 
for  IDA16  binding  assay).  The  slopes  reflect  the  different  affinities  of IDAs 
antibodies for ABPC48.  These  results are  in  good agreement with the  charac- 
teristics of IDAs already described (5). Also represented on Fig.  1 a  the binding 
of ABPC48 antibody to levan, as measured in an ELISA assay with levan adsorbed 
Abbreviations used in this paper. ELISA, Enzyme-linked immunoassay;/3Gal,/~-galactosidase; Id, 
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FIGURE  1.  Binding assays  for ABPC48  idiotype and anti-levan activity. (a)  The  idiotypic 
pattern of ABPC48 is revealed by sandwich assays using homologous monoclonal antibody 
adsorbed on microtiter plates (1 pg/ml) and the same monoclonal antibody conjugated to/3- 
galactosidase (5 ng conjugate per assay) respectively IDA10 (O), IDA16 (/X), IDAI7 (O), and 
I DA23 (&). For anti-levan activity (.) microtiter plates are coated with 50 pl of bacterial levan 
(mol  wt  2  x  105; 10  pg/ml).  The  binding of ABPC48  is  revealed  by sheep  anti-mouse 
immunoglobulin  antibodies conjugated to 13-galactosidase (20 ng per assay). (b) The idiotypic 
pattern of ABPC48 is analyzed by a beterologous sandwich assay. Adsorbed antibodies are 
IDA10  (open  symbols) or  IDA16  (closed  symbols).  B-galactosidase  conjugates are  IDA10 
(circles) or IDA 16 (squares). 
on  microtiter  plates.  The  low values obtained  may reflect  the  low affinity  of 
ABPC48 for levan but also the isotype specificity of the 13-galactosidase  labeled 
sheep anti-mouse Ig antibodies. The binding of ABPC48 to levan is used in this 
study as  a  standard  binding  for  the  anti-levan  activity.  Therefore,  very high 
values in  equivalent  ABPC48  are  obtained  for anti-levan  titer  in  sera.  In  the 
analysis reported below, we always studied sera at dilutions for which binding is 
proportional  to the concentration  of idiotype; several dilutions were assayed to 
control that this was indeed the case. In Fig.  1 b, homologous and heterologous 
binding  assays  with  IDA10  and  IDA16  are  represented.  The  specificity  of 
heteroiogous assays is established by the fact that both monoclonal or polyclonal 
antibodies  raised  against  either  IDA10  or  IDA16--two antibodies  shown  to 
present no cross reactivities (5, 10)--are not detected in such assays. Anti-IDA 10 LEGRAIN  AND  BUTTIN  875 
and  anti-IDA16  antibodies,  even  when  mixed  together  are  not  detected  in 
heterologous assays, whereas they are revealed in homologous assays (results not 
shown). The two heterologous binding assays have intermediate relative sensitiv- 
ities as compared to the homologous ones. So, they allow us to prove the existence 
of two different idiotopes on the same molecule. 
UPC 10 as ABPC48 also binds to ~2-6 fructosan linkages. In a previous study, 
we have shown that UPC 10 shares some A48 idiotopes (5). The data depicted in 
Fig.  2  indicate  that  two  monoclonal  antiidiotypic  antibodies  (i.e.  IDA10  and 
IDA16) recognize A48 idiotopes expressed on UPC10. In contrast,  IDA17 and 
IDA23 monocional antibodies do not bind to UPC10. Sandwich binding assays 
for UPC10 performed with IDA10 and IDA16 are respectively 15 and 5 times 
less sensitive than with ABPC48. This is a confirmation of a weaker interaction 
between UPC10 and  these  two monoclonal  antibodies  (5).  These  data  are  in 
agreement  with  the  previous  results  which  showed  that  UPCI0  was  a  poor 
inhibitor  of the binding  of ABPC48 to IDAs antibodies (50 #g/ml  vs.  50 ng/ 
ml). So it must be stressed that the sandwich binding assays used for the analysis 
of unknown heterogenous populations of antibodies allow detection of idiotypic 
determinants related to those of ABPC48 even when the interactions are weaker. 
By classical inhibition binding assays, such structures could have been missed. 
Analysis of Anti-levan  Titer and Idiotype Expression in BALB/c Mice.  Bacterial 
levan is an environmental antigen that stimulates continuously the specific clones 
as assessed by significant hemagglutination  titers in the sera of animals of various 
species (mouse,  horse,  guinea pig,  etc.) that  have not been deliberately immu- 
nized. Therefore, we have studied the age-dependent variation of the concentra- 
tion of anti-levan antibodies and A48 idiotopes in BALB/c sera. The results are 
depicted in  Fig.  3  for sera of groups of BALB/c mice bled at different ages 
before any intentional immunization.  The anti-levan titer increases with the age 
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FIGURE 2.  Relative  sensitivity of  several  idiotypic  binding assays.  Idiotypic  pattern  of 
ABPC48 (open symbols) or  UPC10  (closed symbols) myeloma proteins are analyzed with 
several monoclonal antibodies: IDA10 (A); IDAI6 (O); 1DAI 7 (V); and IDA23 (I--I). 876  ABPC  48  CROSS-REACTIVE  IDIOTOPES  IN  BALB/c  MICE 
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FIGURE 3.  Idiotypic expression and anti-levan activity in sera of BALB/c mice at different 
ages. Mice were bled at the indicated age, injected with 50/~g levan (mol wt 2 x  107) and bled 
again 7 d  later. Individual analysis was made for the anti-levan activity (A) and the presence 
of idiotypic  determinants:  Idl0  (B),  Idl6  (C),  and  Idl7  (D).  The  equivalent amount  of 
ABPC48 is calculated from a standard binding assay of ABPC48 protein. Geometric means of 
values and standard deviation for preimmune (0) and immune (O) sera are represented. Four 
to six animals were analyzed at each age. The black thick stroke shows the difference between 
preimmune and immune sera. Values located at zero level are background. 
of the mice (panel A).  Idl0 is detected at any age and this expression does not 
increase with age (panel B). Id16 is detected for some mice and not for others 
(panel C) and Id17 is undetectable (panel D). The limit of the detection for the 
different assays was -~ 1-5 t~g equivalent ABPC48 per milliliter  of serum  (sera 
were diluted  at  least  50  times  to avoid any background  effect by nonspecific 
adsorption  on plastic plates).  After bleeding,  mice were injected with bacterial 
levan and bled again 7 d later. These results are represented in Fig. 3. The anti- 
levan  titer,  the  expression  of Idl0  and  Id16  are  increased;  Id17  level  is  still 
background.  The  magnitude  of the  response  is  different  from  one  mouse  to 
another  (see individual  results for several mice in Table II) and the expression 
of Id16 is particularly enhanced (10 to 100 times). 
At this point,  it appears  clearly that  Idl0 and  Id16  expression  is correlated 
with the anti-levan response, whereas Id 17 expression could not be induced at a 
detectable level by this antigen.  Lieberman et al. had shown (3) that the immu- 
nization with levan elicits two kinds of antibodies: a first set is specific for/32-1 
fructosan linkages which cross-reacts with/32-6 fructosan linkages and the second LEGRAIN  AND  BUTTIN  877 
one binds specifically/32-6  polyfructosans (ABPC48 binds/32-6 polyfructosans). 
We measured the inhibition of the levan binding assay by several polyfructosan 
molecules  (Table  I).  Inulin inhibits only partially  the  levan  binding activity  of 
preimmune  and  immune  sera,  plant  levan  (/32-6  polyfructosan)  does  inhibit 
nearly  complete  anti-levan  activity,  whereas  bacterial  levan  (tool  wt  5  ×  10 4, 
carrying  both  antigenic  determinants  of/32-1  and /32-6  polyfructosans)  com- 
pletely inhibits this binding. We concluded from that study that the majority of 
the anti-levan antibodies detected  have a/32-6  polyfructosan binding site.  Inhi- 
bition of binding to idiotype  by bacterial  levan  is also represented  in Table  I. 
This inhibition is complete, either for preimmune or immune sera analysis except 
for one mouse (group 8 wk, number 1) that presents a weak percentage of Idl0 + 
immunoglobulins without detectable anti-levan activity. After immunization with 
levan, this mouse increases considerably its levan-inhibitable Id 10 expression but 
still  keeps  the  same  expression  of non-levan-inhibitable  Idl0  molecules.  With 
this exception  and from  these  inhibition experiments  we  conclude  that nearly 
every  Idl0 ÷  and  Idl6 +  molecules  that  are  present  in  these  preimmune  and 
immune sera have a levan binding site. 
Molecular Linkage Between IdlO and Id16.  To establish a possible distribution 
of Idl0  and  Idl6  idiotopes  on the  same  molecule  (Idl0+-Idl6 + molecule),  we 
used the heterologous  binding assays depicted  in  Fig.  1 b.  Only molecules  that 
interact with both IDA10  and IDA16  are revealed  by these assays. The results 
obtained  with several  sera are  presented  in Table  II.  Values are  expressed  in 
micrograms  equivalent  of ABPC48  per  milliliter.  Immunoglobulins  with both 
TABLE  I 
Inhibition of Binding Assays with Polyfructosan 
Inhibition (%) of levan binding assay by: 
Inulin  Plant levan  Bacterial levan 
Mice  (#M)  (#M)  (uM) 
1.5  30  6  ×  10-2  6  2 ×  I0  -s  0.2 
Inhibition (%) of idi- 
otype binding assay 
Id l0  Id 16 
4 wk no. 2 
p.s.  18  31  63  82  88  100  100  100 
i.s.  15  23  43  86  79  100  100  100 
6 wk no. 3 
p.s.  13  33  43  100  77  100  100  100 
i.s.  3  16  60  98  80  100  100  100 
8 wk no.  1 
p.s.  12  12  50  100  73  I00  62(2.4)*  I00 
i.s.  18  28  56  100  100  100  98(2.8)  100 
t 2 wk no. 2 
p.s.  9  27  53  88  81  100  100  100 
i,s.  17  37  27  85  82  100  98(2.6)  100 
The inhibition of levan binding assay is performed with inulin (/32-1;  mol wt 2,500), plant levan 
(/32-6;  mol  wt  7,500)  and bacterial  levan  (/32-1  and j32-6;  mol wt  5  x  104).  The  inhibition of 
idiotype binding assay is performed with bacterial levan (mol wt 5 ×  104; 0.2 uM). 
* Levan noninhibitable Idl0 molecules (#g/ml). p.s., preimmune serum; i.s., immune serum 7 d after 
injection of 50 tag bacterial levan (mol wt 2 ×  107). 878  ABPC  48  CROSS-REACTIVE IDIOTOPES IN  BALB/c MICE 
TABLE  II 
Binding Assays for Id l O+-Id l 6 + Molecules 
Mice 
Before immunization  After immunization  (7 d) 
*IDA10  IDAI6  IDA10  IDA16  IDA10  IDAI6  IDAI0  IDA16 
IDA10  IDAI0  IDAI6  IDA16  IDA10  IDA10  IDA16  IDA16 
4 wk 
no. 1  6.8  7.1  0  0  11  13.1  6.4  5 
6 wk 
no. 1  7.5  11.7  7.2  6  35  36  22.4  27 
no. 2  17.5  7.8  0  0  91  21  1.6  0 
no. 3  7.3  4.7  4  1  80  91  57.6  65 
7 wk 
no. 1  23  18  19.2  19  175  250  130  148 
8 wk 
no. 1  4.3  7.9  3.2  3  150  200  375  450 
10 wk 
no. 1  4.2  4  2.8  1  75  74  12  10 
no. 2  7.3  3.7  0  0  79  43  2  I 
12 wk 
no. 1  2.6  2.5  0  0  8.8  9  4.4  11.5 
no. 2  35  28  28.4  25  93  120  60.8  83 
Homologous and heterologous binding assays with IDA  10 and IDA  16 are represented (for details, 
see Fig. 1 b). Values are given in equivalent  micrograms of ABPC48 per milliliter, calculated  from 
a standard binding assay with ABPC48 (Fig. 1 b). Immune sera were obtained 7 d after injection of 
50 ug bacterial  levan (mol wt 2 x  107). 
adsorbed on plastic  Monoclonal antibodies 
conjugated to 13gal " 
idiotopes are present in most analyzed sera. The heterologous binding assay with 
IDA10  conjugated  to  13-galactosidase  allows  detection  of molecules  expressing 
Id 16 that are  not detected  in the  homologous Id 16  binding assay, as expected 
from the  better  sensitivity  of IDA10-13gal than  IDA16-13gal binding  assays  (see 
Fig.  1 b).  These  experiments  also  give  information  on  qualitative  aspects  of 
idiotype expression. Since the results are given in micrograms of ABPC48 protein 
equivalent, sera that give about the same results in the four assays contain mostly 
Idl0+-Idl6 +  molecules  similar  to  ABPC48  (for  example,  mice  No.  1  from  6-, 
7-, and 8-wk groups).  On the contrary, one detects in several sera large amounts 
of Idl0  and very low amounts of Idl6  (for example,  mice No.  2  and 6-and  10- 
wk  groups).  In these  sera,  molecules  with  the  Idl0  idiotope  present  structural 
differences  with  ABPC48  that do not allow  the binding of IDA16  with a  good 
affinity,  even  if determinants  related  to the  Idl 6  idiotope  are  actually present 
on these  molecules,  as  is  proven by the positive  results  with  the  more  sensitive 
heterologous assay. 
The molecular linkage between the Idl 0 and Idl6  idiotopes was confirmed in 
binding inhibition  assays.  IDA 16 binding molecules were no longer detected  in 
dilutions  of sera preincubated  with  IDA10  protein  (10 #g/ml)  and  then  tested 
in  the  IDA16-~gal  homologous  binding  assay.  In  the  reverse  test,  IDA16  (10 
/~g/ml) is a  poor inhibitor (10-30%) of the binding of molecules detected in the LEGRAIN  AND  BUTTIN  879 
IDA10-C/gal  homologous  binding  assay,  when  the  mice  have  few  molecules 
detectable  by IDA-16/3gal  homologous  binding  assay  (results  not  shown).  For 
these mice, the results with the heterologous binding assays (Table II) prove that 
the detected molecules have a  very low affinity for IDA16.  So it is difficult to 
conclude that Id 10 + molecules without Id 16 idiotope are present in the analyzed 
sera. 
Long-lasting Idiotype Expression.  The level of the natural expression of Id 10  +- 
Idl6 + molecules detected in nonimmunized mice does not quantitatively corre- 
late  with  the  natural  anti-levan  titer  (Fig.  3)  although  these  molecules have a 
levan binding site and therefore contribute to the anti-levan titer. To obtain a 
more  precise  estimation  of  their  induction  after  stimulation  with  levan,  we 
performed a  kinetic study. Results are presented on Fig. 4. The enrichment in 
Id 10+-Id 16  + molecules is indeed substantial: following a peak at day 6 (or slightly 
earlier) a  drop is observed but these molecules remain during several weeks at 
10-20 times above the level detected before immunization. Anti-levan activity is 
still high during that time; it then decreases markedly but remains noticeable for 
over 8 wk. To appreciate the contribution of Idl0+-Idl6 + molecules to the anti- 
levan  titer,  we  attempted  to  inhibit  the  levan  binding  assay by preincubating 
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FIGURE 4.  Kinetics  of anti-levan and idiotypic response. 12 wk old mice were bled twice 
before the injection of levan (50 ttg intraperitoneally; tool wt 2 × 107) and then bled again at 
different times. Antilevan (I), Idl0 (T), Id16 (V), and Id17 (r-I) expression were measured in 
individual sera. Geometric means and standard deviation are represented. In this experiment, 
ABPC48 protein gives 0.1 unity of optical density at the following concentrations: 700, 65, 
200, and 20 ng/ml for respectively  antilevan, Idl0, Id16, and Id17 binding assays. Sera were 
diluted 500 times excepted for Id 17 assay (100 times). 880  ABPC  48  CROSS-REACTIVE  IDIOTOPES  IN  BALB/c  MICE 
dilutions of sera with a known concentration of Fab IDA 10 (it is not possible to 
use IDA10 complete protein for inhibition since we use an antiimmunoglobulin 
conjugate to reveal anti-levan  activity). We first determined  that  the anti-levan 
activity of ABPC48 is completely inhibited at a concentration of 0.250 #g/ml of 
Fab IDA10.  We then used a  20 times greater concentration  of Fab IDA10 for 
inhibition experiments with sera. Very few sera presented a significant inhibition 
of anti-levan  activity  (results  not  shown).  Thus,  Idl0 +  molecules  represent  a 
minor component of the anti-levan response of BALB/c mice or, alternatively, 
IDA 10 is a poor competitor with the levan binding site of these molecules. 
On  Fig.  4  we also represented  the expression of the  Idl7  idiotope.  For this 
assay,  sera  were diluted  100-fold,  whereas  for  the  Idl0,  Idl6  and  anti-levan 
assays they were diluted 500-fold.  Natural  expression of Idl7  is detectable for 
this group of mice and corresponds to ~2  t~g equivalent ABPC48 per milliliter 
(to be compared to 20 •g/ml  for Idl0 and Idl6). Idl7 level was found constant 
at the different bleedings made during the anti-levan immunization. 
Discussion 
Most  of  the  work  published  on  idiotypic  expression  deals  with  idiotypic 
induction  after  immunization  (2).  Preimmune  sera  have  rarely  been  analyzed 
except as negative controls. The absence of sensitive and specific assays imposed 
as a rule to consider preimmune sera activities as background.  However, several 
attempts (11-14) have been made to define natural idiotypic activities by means 
of polyclonal antiidiotypic antibodies. In such systems, the immunoglobulins that 
are detected may correspond  to various structures.  The  quantitative  sandwich 
binding assay carried out with monoclonal antibodies allows the detection of low 
concentrations of idiotypic determinants.  Moreover, sandwich assays and inhibi- 
tion binding assays do not reveal the same set of molecules: the latter detect only 
molecules that,  in  terms of location of their  binding  site and  in terms of their 
affinity,  are  competitors  in  the  idiotype-antiidiotype  interaction  (in  particular 
molecules homologous to either idiotype or antiidiotype).  In contrast,  sandwich 
binding assays allow detection of any immunoglobulin  that binds specifically to 
the monoclonal  antiidiotypic antibodies.  A  binding assay was already used for 
the  detection  of idiotypes by Reth  et ai.  (15)  but  this  assay was restricted  to 
antibodies constituted with a 3,1 chain as it is the case for antiNP antibodies. The 
assay  described  here  allows,  in  principle,  the  detection  of antibody  of any 
antigenic  specificity. Sandwich  binding  assays have been already described for 
the study of allotypic specificities (16). 
The analysis of preimmune sera from mice at different ages for the presence 
of ABPC48 cross reactive idiotopes leads to the remarkable conclusion that Id 10 
determinants  are  detected  in  all  sera.  By  binding  inhibition  assays  and  by 
heterologous sandwich binding assays it is also shown that at least a  fraction of 
the immunoglobulins with the Idl 0 idiotope also possess the Idl 6 idiotope. All 
Id 10+-Id 16  + molecules have a levan binding site as shown by binding inhibition 
assay with bacterial levan.  By the homologous sandwich assay that detects Idl 6 
idiotope,  it is  not possible to detect  Idl6  in all sera.  The  limitation,  however, 
could be the sensitivity of this assay. 
The  anti-levan  activity is  measured  by a  binding  assay to bacterial  levan,  a LEGRAIN  AND  BUTTIN  881 
polyfructosan with both/32-1  and/32-6 determinants. In preimmune sera, the 
anti-levan titer increases with the age of the mice. The binding inhibition assay 
with different polyfructosans shows that,  whatever the age of the mice, /32-6 
polyfructosan (i.e. plant levan) is far more inhibitory than/32-1  polyfructosan 
(i.e. inulin). Oligofructosans are not available but the molecular weights of plant 
levan (7,500) and insulin  (2,500)  are comparable enough to allow to consider 
that the major component of the natural anti-levan activity is directed against 
/32-6  polyfructosans.  Actually,  the  weak  inhibitory  power  of inulin  can  be 
interpreted with the existence of antibodies able to bind with different affinities, 
the two  kinds of polyfructosans, as proposed  by  Lieberman et al.  (3).  Levan 
injection leads to an increase of anti-levan titer correlated with an increase of 
Idl0+-Idl6 +  immunoglobulin  expression.  When  mice  present  a  low  natural 
expression of Idl 7, this remains constant after immunization. Work is in progress 
to  characterize  Ig  with  Idl7  idiotope.  The  magnitude  of the  Idl0+-Idl6 ÷ 
response is variable but does not depend on the age of the mice. The fast increase 
of Idl 0+-Id 16 + molecules (peak at 5-7 d) suggests that preactivated clones are 
expanded. The same analysis as for preimmune sera shows that Idl6 determi- 
nants  are  found  on  Idl0  ÷  immunoglobulins  that  are  anti-levan  antibodies. 
Kinetics analysis shows that Idl 0 and Idl 6 increased expression remains stable 
for at least 7  wk and parallels the anti-levan titer enhancement. In conclusion, 
anti-levan antibodies with two ABPC48  idiotopes are found in normal sera at 
constant levels. Their natural level does not increase with the age of the mice as 
it  is  observed  for  the  natural  anti-levan  titer  but  they contribute,  as  minor 
components, to the immune response to bacterial levan. The presence of Id 10 ÷- 
Idl6 ÷  molecules  with  anti-levan  activity  may  be  the  manifestation  of early 
immunization with  environmental levan.  If so,  steady level of these idiotypes 
during the aging of the mice requires the setting of a control mechanism. One 
possibility might be the production of autoantiidiotypic antibodies as it has been 
proposed for the anti-inulin response (17). 
ABPC48  idiotype  was  not  found  in  the  anti-levan  response  of  normal 
BALB/c  mice analyzed by  Lieberman  et  al.  (3).  Several  hypotheses may be 
proposed to explain this discrepancy. First, the origin of levan molecules is not 
the same (B. subtilis in this work and Aerobacter levanicum for Lieberman's work). 
Secondly, and more important are the differences in the antiidiotype probes and 
assays that were used: inhibition of hemagglutination with polyclonal antibodies 
as used by Lieberman et al. only permits the detection of antibodies that compete 
for the binding between the idiotype (here ABPC48) and the more representative 
(and with greater affinity) antiidiotypic antibodies raised against it; in contrast, 
we  used  monoclonal  syngeneic antiidiotypic  antibodies  in  sandwich  binding 
assays. 
The demonstration that ABPC48 idiotopes are present in preimmune sera has 
some bearing on the interpretation of recent results obtained by Bona et al. (18). 
These authors propose that physiologically relevant idiotypic interactions could 
be  mainly a  two  partners  (+,  -)  regulatory system where antiepitope  elicits 
antiidiotope antibodies and antiidiotope antibody elicits idiotope-bearing mole- 
cules. An important statement in this model is that idiotope-positive molecules 
with an antigen binding site (i.e. levan) may be induced by the manipulation with 882  ABPC 48  CROSS-REACTIVE IDIOTOPES IN  BALB/c MICE 
antiidiotypic antibodies, and it is further suggested that this reflects the activation 
of silent clones (19, 20); such manipulations may indeed facilitate the emergence 
of ABPC48 idiotype in the anti-levan response; however, since several ABPC48 
idiotopes are  already present  in  normal  sera,  it  is difficult to decide whether 
idiotypic  induction  follows  the  recruitment  of silent  clones  rather  than  the 
expansion of preactivated ones. 
By immunization with monoclonal antiABPC48 antiidiotypic antibodies (IDA), 
we obtained polyclonal and monoclonal antibodies, some of them with a definite 
albeit very low affinity for levan (21, 22). Even in this case, we cannot exclude 
the  fusion  event  with  a  B  cell  derived  from  a  clone  activated  before  the 
immunization with the monoclonal IDA. However, a fine analysis of the kinetics 
of response  to  different  monoclonal  IDAs  shows  a  transient  increase  of the 
expression of Id 10+-Id 16  + molecules with a levan binding site (22). This indicates 
that  the  injection  of an  antiidiotypic  antibody  permits  expansion  of activated 
clones that express idiotype-positive antigen binding immunoglobulins: such cells 
are likely also to act as partners in cell fusions. 
Our results clearly show a discrepancy between a natural idiotypic expression-- 
which remains constant--and the natural titer against a bacterial antigen--which 
rises during  life time.  Further experiments are needed to discover the controls 
that govern ABPC48 cross-reactive idiotype expression and limit the expansion 
of relevant B cell clones. 
Summary 
Using monoclonal  antiidiotypic antibodies,  we developed a  sensitive binding 
assay that  detects  molecules  with  one  or  with  two  idiotopes  of the  ABPC48 
idiotype.  ABPC48  cross-reactive  idiotypes  were  thus  shown  to  be  present  in 
substantial amounts in sera of nonimmunized mice. Levan binding sites are found 
on these idiotypes. During the life time of the mice, the natural anti-levan titer 
increases while ABPC48 idiotypic expression remains constant,  suggesting dif- 
ferent  controls  for  these  two  activities.  On  the  other  hand,  ABPC48  cross- 
reactive idiotypes participate--as  minor components--in  the response that  fol- 
lows a  deliberate  immunization  with  bacterial  levan.  This  induction  process is 
likely to reflect the selection of idiotopes expressed by the B cell clones preacti- 
vated in sera of nonimmunized  mice rather than  the activation of silent clones. 
We suggest  that  a  similar  situation  might  explain  the  reported  emergence  of 
ABPC48  idiotypes in  animals  primed  with  antiidiotypic  antibodies and  subse- 
quently stimulated with levan. 
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